Ameena El-Bibany

Seed Investor

2021 - Current

Investor and Board Member

2023

Investor and Board Member

2020

Partner

2019 - 2024

Partner

2014 - 2019

Exits: Precision NanoSystems (acquired by Danaher) Apama Medical (acquired by Boston Scientific) Loop Genomics (acquired by Element Bio) Active Investments: Exo (RA Capital, BlackRock, BOLD, Applied Ventures, Intel, Action Potential VC) Evonetix (Foresite Capital, DCVC, Draper Esprit) GRO Biosciences (Leaps by Bayer, Redmile, Innovation Endeavors) Volta Labs (Maverick Ventures, Khosla Ventures, Casdin) Activ Surgical (GreatPoint Ventures, 8VC) Aspect Biosystems (Radical, Pangaea Ventures) Unnatural Products (ARTIS Ventures)

Stem Cell Research Assistant

2012 - 2013

• Tested conditions for optimal induction and stabilization of equine induced pluripotent stem cells (iPSCs). • Independently conducted secondary immunofluorescence staining of Oct-4 and CDX2 genes in equine inner cell mass and bovine embryos; collected data using a fluorescence microscope. • Cultured and passaged equine fibroblast and Chinese hamster ovary (CHO) cell lines in sterile conditions.

Microbiome Data Analyst

2013 - 2013

• Analyzed large metagenomic dataset of gut microbiota present in avian species from Papua New Guinea. • Calculated Shannon Indices and conducted Principal Component Analyses to compare gut bacterial diversity and composition, respectively, between sexes and among individuals of differing diet types. • Presented at the Society for Integrative and Comparative Biology National Conference, Austin, Texas, January 2014 — and — at the California Academy of Sciences, San Francisco, California, August 2013. Research Experience for Undergraduates Grant funded by the Robert T. Wallace Endowment for Undergraduate Research.

DNA Repair Researcher

2013 - 2013

• Discovered interspecific differences in both genotoxic susceptibility and DNA repair capacity in coelomocytes of echinoderm species with varying lifespans and a lack of decline in DNA repair capacity with age (contrary to mammals). • Quantified DNA strand break levels via Fast Micromethod Assay following acute exposure to UV-C or hydrogen peroxide. • Presented at the Bermuda Institute of Ocean Sciences, St. George’s, Bermuda, November 2013. Research Experience for Undergraduates Grant funded by the National Science Foundation.

Research and Development Scientist

2012 - 2012

• Demonstrated a 25% improved yield of targeted DNA extraction through new method compared to standard company procedure, while maintaining near-100% removal of undesired drug markers. • Designed and constructed plasmids through subcloning. Detected presence and quantified amount remaining ampicillin marker by Southern blot and dot blot, respectively. • Presented at Novozymes, Inc., Davis, California, September 2012.